Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACTICS: Tezosentan in Cardiac Surgery with PH
NCT00458276Phase 3Terminated
- Sponsor
- Idorsia
- Start
- Apr 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of tezosentan in pulmonary hypertension (PH), sponsored by Idorsia. Started Apr 2007; status: terminated.
02
Drugs
tezosentan
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00458276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458276.